Viewing Study NCT03490669


Ignite Creation Date: 2025-12-24 @ 10:48 PM
Ignite Modification Date: 2026-01-16 @ 3:50 PM
Study NCT ID: NCT03490669
Status: COMPLETED
Last Update Posted: 2024-04-05
First Post: 2018-02-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study to Evaluate Safety, PK, PD, Immunogenicity & Antitumor Activity of MSC-1 in Patients With Adv Solid Tumors
Sponsor: AstraZeneca
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Solid Tumors View
None Pancreatic Cancer View
None Non Small Cell Lung Cancer View
None Ovarian Cancer View
Keywords: